Science News
Ozempic-Type Drugs Flopped on Alzheimer’s, but Review Sees Brain Upside
A Science review finds GLP-1 drugs like semaglutide did not slow Alzheimer's, yet may help people with obesity or diabetes keep memory and focus.
Space, Earth and the natural world, explained.
A Science review finds GLP-1 drugs like semaglutide did not slow Alzheimer's, yet may help people with obesity or diabetes keep memory and focus.
A Yale analysis of 51 studies found metformin, semaglutide and diet plus exercise lowered epigenetic age. Supplements showed little measurable effect.
A Danish study found early-pregnancy use of Ozempic-type drugs raised preterm birth odds only when prescribed for diabetes, not for weight loss.
We use analytics cookies to see which articles are read. No ads cookies. Privacy policy